Catch up on the top radiology content of the past week.
|Articles|November 26, 2016
Medic Vision: ‘Only FDA-cleared 3rd Party XR-29 Solution at RSNA’
Author(s)Diagnostic Imaging Staff
Medic Vision will present at RSNA 2016 its XR-29 solution.
Advertisement
Medic Vision Imaging Solutions will present at RSNA 2016 their FDA-cleared SafeCT-29.
SafeCT-29 is the first and only FDA-cleared third party XR-29 solution that helps meet the NEMA XR-29 (Smart Dose) standard, according to a release. Practices that meet the standard can avoid a CMS penalty, which will rise to 15% in 2017 for non-compliant scanners.
SafeCT-29 is CT-vendor neutral and offers full compliance with all of the XR-29 Dose Check and RDSR requirements, according to the release. The system is fully automatic and enables the technologist to maintain their existing workflow, the release said, it connects to the CT console, analyzes data in real time, and alerts the operator if the dose is too high. After the scan, SafeCT-29 generates Radiation Dose Structured Reports, as required by the XR-29 standard, the release said.
Medic Vision will be at booth 7938.
Advertisement
Related to this article
In a new podcast episode, Joseph Cavallo, MD, MBA, offered his perspective on AI integration, potential efficiency gains, navigating post-deployment monitoring and how to incorporate AI literacy into radiology resident training.
The FFR-IQ software recently demonstrated a 92.2 percent sensitivity for non-invasive estimation of fractional flow reserve (FFRC) based on coronary CT angiography (CCTA) scans.
Catch up on the top radiology content of the past week.
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
Catch up on the top radiology content of the past week.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
3
FDA Clears AI-Enabled FFR-IQ Software for Estimating Fractional Flow Reserve from CCTA
4
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
5